Zogenix, Inc. (ZGNX): Price and Financial Metrics

Zogenix, Inc. (ZGNX)

Today's Latest Price: $21.29 USD

0.29 (1.38%)

Updated Oct 23 6:55pm

Add ZGNX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZGNX Stock Summary

  • With a price/sales ratio of 233.88, Zogenix Inc has a higher such ratio than 98.23% of stocks in our set.
  • Over the past twelve months, ZGNX has reported earnings growth of 221.86%, putting it ahead of 94.01% of US stocks in our set.
  • Revenue growth over the past 12 months for Zogenix Inc comes in at 354.63%, a number that bests 98.1% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to ZGNX, based on their financial statements, market capitalization, and price volatility, are CMRX, ABUS, CSLT, AGYS, and RBBN.
  • Visit ZGNX's SEC page to see the company's official filings. To visit the company's web site, go to www.zogenix.com.

ZGNX Stock Price Chart Interactive Chart >

Price chart for ZGNX

ZGNX Price/Volume Stats

Current price $21.29 52-week high $57.22
Prev. close $21.00 52-week low $16.65
Day low $20.63 Volume 857,600
Day high $21.30 Avg. volume 1,132,534
50-day MA $21.51 Dividend yield N/A
200-day MA $27.89 Market Cap 1.18B

Zogenix, Inc. (ZGNX) Company Bio

Zogenix develops and commercializes therapies for the treatment of central nervous system disorders. The company was founded in 2006 and is based in San Diego, California.

ZGNX Latest News Stream

Event/Time News Detail
Loading, please wait...

ZGNX Latest Social Stream

Loading social stream, please wait...

View Full ZGNX Social Stream

Latest ZGNX News From Around the Web

Below are the latest news stories about Zogenix Inc that investors may wish to consider to help them evaluate ZGNX as an investment opportunity.

Zogenix: 40% Off And Fundamentals Remain Intact

On June 25th, Zogenix’s lead product Fintepla was approved by the FDA. Since that positive announcement, the stock is down 38%, closing at $17.50 on September 25th. What happened and what does one do now? Our view is that the stock’s decline was due to multiple factors. First, the supply-demand...

Illumination Capital on Seeking Alpha | September 30, 2020

Zogenix prices $200M convertible senior notes offering

Zogenix (ZGNX) prices $200M 2.75% convertible senior notes due 2027 in a private offering to institutional buyers.Initial purchasers has an option to purchase an additional  $30M notes. From and after July 1, 2027, noteholders may convert their notes at any time at their election until the close of business on the...

Seeking Alpha | September 24, 2020

Zogenix, Inc. Announces Proposed Convertible Senior Notes Offering

EMERYVILLE, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX) today announced its intention to offer, subject to market and other…

GlobeNewswire | September 22, 2020

Zogenix to Release Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 5

EMERYVILLE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the three and six months ended June 30, 2020, after the market close, and will host a corporate update conference call and webcast on Wednesday, August 5, 2020, at 4:30 PM Eastern Time. Conference Call Details Wednesday, August 5, at 4:30 PM Eastern Time / 1:30 PM Pacific Time Toll Free:866-269-4260  International:323-347-3612  Conference ID:8881331 Webcast:http://public.viavid.com/index.php?id=141049  About Zogenix Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients...

Yahoo | July 29, 2020

Did Hedge Funds Make The Right Call On Zogenix, Inc. (ZGNX) ?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | July 13, 2020

Read More 'ZGNX' Stories Here

ZGNX Price Returns

1-mo 21.66%
3-mo -15.25%
6-mo -25.74%
1-year -52.09%
3-year -44.77%
5-year 82.28%
YTD -59.16%
2019 42.98%
2018 -8.96%
2017 229.63%
2016 -17.57%
2015 34.49%

Continue Researching ZGNX

Want to see what other sources are saying about Zogenix Inc's financials and stock price? Try the links below:

Zogenix Inc (ZGNX) Stock Price | Nasdaq
Zogenix Inc (ZGNX) Stock Quote, History and News - Yahoo Finance
Zogenix Inc (ZGNX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8711 seconds.